IceCure Stock Drops Before The Bell As Nasdaq’s $1 Clock Ticks
IceCure Medical shares fell 8.6% in early U.S. pre-market trading Tuesday, last at $0.2011 and still below Nasdaq’s $1 minimum bid threshold. The company has until Nov. 9 to regain compliance and may consider a reverse split. No new company updates were posted since May 19. Broader U.S. stock futures were mixed to lower ahead of the open.
